Increasing company innovation and competitiveness by implementing R & D and novel health technologies (Q122899)

From EU Knowledge Graph
Revision as of 07:18, 21 October 2020 by DG Regio (talk | contribs) (‎Created claim: summary (P836): The project is aimed at increasing the competitiveness and innovativeness of the ophthalmology office. As part of the investment, the company will fundamentally change its processes in the field of medical activities, by implementing process innovation, will increase the scope of the offer, thanks to the implementation of innovative diagnostic and therapeutic methods, transform the internal organisation and introduce new marketing directions, re...)
Jump to navigation Jump to search
Project in Poland financed by DG Regio
Language Label Description Also known as
English
Increasing company innovation and competitiveness by implementing R & D and novel health technologies
Project in Poland financed by DG Regio

    Statements

    country
    Poland
    0 references
    EU contribution
    256,938.6 zloty
    0 references
    61,665.26 Euro
    exchange rate to Euro
    0.24 Euro
    point in time
    13 January 2020
    0 references
    budget
    570,974.7 zloty
    0 references
    137,033.93 Euro
    exchange rate to Euro
    0.24 Euro
    point in time
    13 January 2020
    0 references
    co-financing rate
    45.0 percent
    0 references
    start time
    19 January 2017
    0 references
    end time
    31 December 2017
    0 references
    beneficiary name (string)
    PROMED OKULISTYKA BORKOWSCY SPÓŁKA JAWNA
    0 references
    beneficiary
    Q2531491
    0 references
    coordinate location

    50°48'32.4"N, 19°7'27.8"E
    0 references
    summary
    Projekt ukierunkowany jest na wzrost konkurencyjności i innowacyjności gabinetu okulistycznego. W ramach inwestycji, firma zmieni zasadniczo procesy w obszarze działalności leczniczej, jaką prowadzi, wdrażając innowację procesową, zwiększy zakres oferty, dzięki implementacji nowatorskich metod diagnostycznych i leczniczych, przekształci wewnętrzną organizację oraz wprowadzi nowe kierunki marketingowe, sięgając po innowacje nietechnologiczne. W wyniku wdrożenia prac B+R, spółka wkroczy w zupełnie nowy poziom usług okulistycznych, co umożliwi wejście na nowe rynki zbytu, powiększając grono klientów, zwiększając przychody oraz zatrudnienie. Efekty te będą możliwe dzięki zakupowi nowoczesnych środków trwałych. (Polish)
    0 references
    The project is aimed at increasing the competitiveness and innovativeness of the ophthalmology office. As part of the investment, the company will fundamentally change its processes in the field of medical activities, by implementing process innovation, will increase the scope of the offer, thanks to the implementation of innovative diagnostic and therapeutic methods, transform the internal organisation and introduce new marketing directions, reaching for non-technological innovations. As a result of the implementation of R & D, the company will enter a completely new level of ophthalmology services, which will allow entering new markets, increasing the number of customers, increasing revenues and employment. These effects will be possible thanks to the purchase of modern fixed assets. (English)
    point in time
    21 October 2020
    0 references

    Identifiers

    Polish Kohesio ID
    RPSL.03.02.00-24-0015/17
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q122899&oldid=6495911"